DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ott PA, Hodi FS, Robert C.
CTLA-4 and PD-1/PD-L1 blockade: New immunotherapeutic modalities with durable clinical benefit in melanoma patients.
Clin Cancer Res 2013;
19: 5300-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.